10:25 AM EST - QLT Inc. : has reported a worse-than-expected first-quarter net loss of US$10.5 million as sales of its key Visudyne eye drug faded 40 percent from a year earlier. QLT, reporting in U.S. dollars, said Friday its January-March revenue fell 42 percent to $11.9 million as its share of profit from the quarter's $36.5 million in worldwide Visudyne sales declined to 21.5 per cent from 24.5 percent a year earlier. QLT Inc.
shares T.QLT are trading down 3 cents at $3.99.
